Cardinal Health Inc. (CAH)

Cardinal Health Inc. (CAH $158.58)
- $158.58 P/E (TTM): 24.93X Cap: $38.08B
- View CAH Profile
- View Questions on CAH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Cardinal Health Inc. (CAH $158.58)
- $158.58 P/E (TTM): 24.93X Cap: $38.08B
- View CAH Profile
- View Questions on CAH
McKesson Corporation (MCK $711.21)
- $711.21 P/E (TTM): 27.47X Cap: $88.80B
- View MCK Profile
- View Questions on MCK

Q: Hi - do you have a preference between these two drug distribution companies? If you would avoid both at this time, then that's fine too!

Read Answer Asked by Doug on March 08, 2024

Intuitive Surgical Inc. (ISRG $516.12)
- $516.12 P/E (TTM): 75.93X Cap: $185.88B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $184.85)
- $184.85 P/E (TTM): 80.88X Cap: $334.30B
- View ABBV Profile
- View Questions on ABBV
Cardinal Health Inc. (CAH $158.58)
- $158.58 P/E (TTM): 24.93X Cap: $38.08B
- View CAH Profile
- View Questions on CAH
Johnson & Johnson (JNJ $164.36)
- $164.36 P/E (TTM): 18.21X Cap: $393.87B
- View JNJ Profile
- View Questions on JNJ
Stryker Corporation (SYK $387.32)
- $387.32 P/E (TTM): 52.62X Cap: $148.81B
- View SYK Profile
- View Questions on SYK
Guardant Health Inc. (GH $45.64)
- $45.64 Cap: $5.75B
- View GH Profile
- View Questions on GH

Q: Hello 5i Team.

Thank you for all the insights into investing - it has been profitable both educationally and financially.

7% of our portfolio is in geared to health care with a holding of 5 stocks , GUD - (slightly underwater but is the hopeful flyer), Medtronic - MDT, Cardinal Health - CAH, Abbvie - ABBV, Johnson & Johnson- JNJ. In an effort to reduce the overall number of stocks in our TFSA, RRSP and taxable accounts I was considering liquidating CAH and JNJ and either purchasing more ABBV or adding SYK, unless of course you can recommend another US health care stock. JNJ and and CAH have been the laggards of the US group since my initial purchases. I realize MDT and SYK might be similar but i do believe surgeries should increase in 2022.

I enjoy reading your resources and recommend it often.

Kevin

Read Answer Asked by Kevin on June 30, 2021

Walgreens Boots Alliance Inc. (WBA $11.52)
- $11.52 Cap: $9.94B
- View WBA Profile
- View Questions on WBA
Cardinal Health Inc. (CAH $158.58)
- $158.58 P/E (TTM): 24.93X Cap: $38.08B
- View CAH Profile
- View Questions on CAH
Medtronic plc. (MDT $89.70)
- $89.70 P/E (TTM): 24.82X Cap: $114.81B
- View MDT Profile
- View Questions on MDT

Q: Hi Everyone at 5i! I am in the process of reducing the number of holdings in my US portfolio . I own several related to healthcare. I just recently sold off my JNJ at a profit. I am under water on CAH and WBA. I propose to sell CAH and WBA at a capital loss to offset my gain on JNJ. I intend to keep MDT. Does this seem reasonable to you?. Cheers, Tamara

Read Answer Asked by Tamara on July 29, 2019